New ultrasound technique could sharpen liver surgery decisions

NCT ID NCT01880554

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether using a contrast dye during ultrasound while operating on liver tumors from colorectal cancer helps surgeons make better decisions. 68 patients were enrolled, and doctors compared the surgical plan before and after the contrast-enhanced ultrasound. The goal was to see if the new imaging changed the surgery in a helpful way.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

contrast-enhanced intraoperative ultrasound (device)

What this could lead to

If successful, this could make liver surgery more precise by helping surgeons see tumors they might otherwise miss.

What could go wrong

This is a small, completed phase 2 study, so results need confirmation in larger trials. The technique may not improve outcomes for all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER METASTASES FROM COLORECTAL PRIMARY CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut Bergonié

    Bordeaux, Aquitaine, 33000, France